Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/immunology.3.082
Immunomodulatory Effects of Cell Therapy after Myocardial Infarction
Joseph B Moore 4th1, Marcin Wysoczynski1,*
- 1Diabetes and Obesity Center, University of Louisville School of Medicine, Louisville, KY, USA
Corresponding Author
Marcin Wysoczynski, m0wyso01@louisville.edu
Received Date: December 23, 2020
Accepted Date: February 19, 2021
Moore JB, Wysoczynski M. Immunomodulatory Effects of Cell Therapy after Myocardial Infarction. J Cell Immunol. 2021; 3(2): 85-90.
Copyright: © 2021 Moore JB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Cardiac Stem Cell Therapy, Quo Vadis
Cardiovascular disease causes 30% of global mortality and is still the number one cause of death worldwide. A main patho-physiological process is the coronary disease leading to malperfusion and ischemic cardiac disease as well as cardiac infarction.
Elucidating the Role of Chemokines in Infectious Diseases and Gastric Cancer
Although the prevalence of gastric cancer is decreasing in many developed nations, it is the fourth most prevalent cancer and the second leading cause of cancer-related deaths globally. Around 8 percent of recently diagnosed malignant tumors are stomach cancer, more than 7,00,000 individuals die from gastric cancer yearly. Despite extensive research into new diagnostic and therapeutic methods, the prognosis for individuals with advanced stomach cancer remains dismal, and survival rates have hardly improved. In recent years, many latest innovations have improved our understanding of the molecular mechanisms and modifications that contribute to gastric cancer’s beginning and progression, including several genetic and molecular modifications and mutations.
Diagnostic Value of Lung Ultrasonography in Comparison with Killip Classes after Angiography in Acute Myocardial Infarction: A Study from Iran
Acute myocardial infarction (AMI) with heart failure (HF), is the main cause of increased mortality. Early risk stratification by Killip classification is essential for its management. Today, non-invasive diagnostic methods such as lung ultrasound (LUS) are on the rise due to their ability to provide valuable insights without invasive methods. In this study we aimed to evaluate diagnostic value of LUS in comparison with Killip classes after angiography in AMI patients.
Cytokines (IL-1 β, IL-6, IL-18, TNF-α) in Blood and Cerebrospinal Fluid in Neonatal Hypoxia/Ischemia)
Perinatal brain injury is an important clinical and socioeconomic entity. It is a syndrome of impaired brain function in the early days of life, and it is a consequence of inadequate brain oxygenation before, during or shortly after birth, with high mortality rates and early and late morbidity rates.
Current Advances in CAR T Cell Therapy for Malignant Mesothelioma
Malignant mesothelioma is a relatively rare malignancy arising in the body’s serosal surfaces, with malignant pleural mesothelioma (MPM) being the most common type. It is characterized by local spread within the thorax, poor prognosis and resistance to treatment. The development of various immunotherapeutic options has provided a new way- and hope- in treating cancer patients. Chimeric antigen receptor (CAR) T cell therapy has been proven very successful in treating hematological cancers, like leukemias and lymphomas, and its use is now being tested in solid tumors.